Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@MSollender Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1063180083769176064.png) @MSollender Michelle Solly

Michelle Solly posts on X about $rare, $apge, $capr, $cogt the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1063180083769176064/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXXX +212%
- X Months XXXXXXXXX +13%
- X Year XXXXXXXXX +335%

### Mentions: X [#](/creator/twitter::1063180083769176064/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XX%
- X Months XXX -XX%
- X Year XXX +321%

### Followers: XXXXXX [#](/creator/twitter::1063180083769176064/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:followers.svg)

- X Week XXXXXX -XXXX%
- X Month XXXXXX +1.30%
- X Months XXXXXX +6.40%
- X Year XXXXXX +9.60%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1063180083769176064/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1063180083769176064/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1063180083769176064/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX% [stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXX%

**Social topic influence**
[$rare](/topic/$rare) #35, [$apge](/topic/$apge) #4, [$capr](/topic/$capr) #2, [$cogt](/topic/$cogt) #2, [$fulc](/topic/$fulc) #2, [$mltx](/topic/$mltx) #6, [$mreo](/topic/$mreo) #4, [half of](/topic/half-of) 0.4%, [$abus](/topic/$abus) 0.4%, [$abvx](/topic/$abvx) XXX%

**Top accounts mentioned or mentioned by**
[@crocsanalyst](/creator/undefined) [@a_may_md](/creator/undefined) [@joserestonva](/creator/undefined) [@jq1234t](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@bluejaunt100](/creator/undefined) [@lifeisblank21](/creator/undefined) [@biotenic](/creator/undefined) [@amaymd](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@martinshkreli](/creator/undefined) [@biotechport](/creator/undefined) [@gravityanalyti1](/creator/undefined) [@oncinvestor](/creator/undefined) [@prosperousguy](/creator/undefined) [@vega_n1](/creator/undefined) [@monaco_biotech](/creator/undefined) [@pickingmyown](/creator/undefined) [@sportsbios](/creator/undefined) [@longonlybio](/creator/undefined)

**Top assets mentioned**
[SuperRare (RARE)](/topic/$rare) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Alkermes Inc. plc (ALKS)](/topic/$alks) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Immunovant, Inc. Common Stock (IMVT)](/topic/$imvt) [Incyte Corporation (INCY)](/topic/$incy) [Insmed, Inc. (INSM)](/topic/$insm) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Mist (MIST)](/topic/$mist)
### Top Social Posts [#](/creator/twitter::1063180083769176064/posts)
---
Top posts by engagements in the last XX hours

"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"  
[X Link](https://x.com/MSollender/status/1940005423534547058) [@MSollender](/creator/x/MSollender) 2025-07-01T11:11Z 13.6K followers, 71K engagements


"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"  
[X Link](https://x.com/MSollender/status/1924617438211277122) [@MSollender](/creator/x/MSollender) 2025-05-20T00:05Z 13.6K followers, 58.5K engagements


"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"  
[X Link](https://x.com/MSollender/status/1943039211726344343) [@MSollender](/creator/x/MSollender) 2025-07-09T20:07Z 13.6K followers, 16.8K engagements


"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"  
[X Link](https://x.com/MSollender/status/1943770441400955246) [@MSollender](/creator/x/MSollender) 2025-07-11T20:32Z 13.6K followers, 18.4K engagements


"$CLDX Celldex Reports Results from Phase X Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver in EoE"  
[X Link](https://x.com/MSollender/status/1957896097508274468) [@MSollender](/creator/x/MSollender) 2025-08-19T20:03Z 13.6K followers, 9024 engagements


"(1/3) It's the home stretch for 2025 already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK"  
[X Link](https://x.com/MSollender/status/1973339349103288786) [@MSollender](/creator/x/MSollender) 2025-10-01T10:48Z 13.6K followers, 20.1K engagements


"(2/3) Some intriguing make-or-break data sets for companies as well as some modality readouts are upcoming $DRUG $DYN $ELDN $EWTX $FGEN $FULC $GPCR $IFRX $IMNM $IMVT $INCY $INSM $IRON $JANX $JAZZ $KRRO $LXEO $MIST $MLTX $MREO $MRSN $NKTR"  
[X Link](https://x.com/MSollender/status/1973339816294285641) [@MSollender](/creator/x/MSollender) 2025-10-01T10:50Z 13.6K followers, 4155 engagements


"$PALI Palisade Bio Announces Closing of Upsized $XXX Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option"  
[X Link](https://x.com/MSollender/status/1973842600017998139) [@MSollender](/creator/x/MSollender) 2025-10-02T20:08Z 13.6K followers, 7000 engagements


"$BMEA Offering 🫠"  
[X Link](https://x.com/MSollender/status/1975294875655675982) [@MSollender](/creator/x/MSollender) 2025-10-06T20:19Z 13.6K followers, 8261 engagements


"@jq1234t Next one is $16B at this rate"  
[X Link](https://x.com/MSollender/status/1973857413507002711) [@MSollender](/creator/x/MSollender) 2025-10-02T21:07Z 13.6K followers, 1442 engagements


"$GLTO $ACXP $XBIO What are we doing here"  
[X Link](https://x.com/MSollender/status/1975844511038546426) [@MSollender](/creator/x/MSollender) 2025-10-08T08:43Z 13.6K followers, 6794 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@MSollender Avatar @MSollender Michelle Solly

Michelle Solly posts on X about $rare, $apge, $capr, $cogt the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXXX +212%
  • X Months XXXXXXXXX +13%
  • X Year XXXXXXXXX +335%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX -XX%
  • X Months XXX -XX%
  • X Year XXX +321%

Followers: XXXXXX #

Followers Line Chart

  • X Week XXXXXX -XXXX%
  • X Month XXXXXX +1.30%
  • X Months XXXXXX +6.40%
  • X Year XXXXXX +9.60%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence cryptocurrencies XXXX% stocks XXXX% finance XXX%

Social topic influence $rare #35, $apge #4, $capr #2, $cogt #2, $fulc #2, $mltx #6, $mreo #4, half of 0.4%, $abus 0.4%, $abvx XXX%

Top accounts mentioned or mentioned by @crocsanalyst @a_may_md @joserestonva @jq1234t @aaronrosenblum5 @bluejaunt100 @lifeisblank21 @biotenic @amaymd @adamfeuerstein @martinshkreli @biotechport @gravityanalyti1 @oncinvestor @prosperousguy @vega_n1 @monaco_biotech @pickingmyown @sportsbios @longonlybio

Top assets mentioned SuperRare (RARE) Apogee Therapeutics, Inc. Common Stock (APGE) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Scholar Rock Holding Corporation Common Stock (SRRK) Pfizer, Inc. (PFE) Celldex Therapeutics, Inc (CLDX) Agios Pharmaceuticals, Inc. (AGIO) Alkermes Inc. plc (ALKS) BridgeBio Pharma, Inc. Common Stock (BBIO) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Cytokinetics Inc. (CYTK) Edgewise Therapeutics, Inc. Common Stock (EWTX) Dyne Therapeutics, Inc. Common Stock (DYN) Immunovant, Inc. Common Stock (IMVT) Incyte Corporation (INCY) Insmed, Inc. (INSM) Disc Medicine, Inc. Common Stock (IRON) Janux Therapeutics, Inc. Common Stock (JANX) Jazz Pharmaceuticals, Inc. (JAZZ) Mist (MIST)

Top Social Posts #


Top posts by engagements in the last XX hours

"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"
X Link @MSollender 2025-07-01T11:11Z 13.6K followers, 71K engagements

"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"
X Link @MSollender 2025-05-20T00:05Z 13.6K followers, 58.5K engagements

"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"
X Link @MSollender 2025-07-09T20:07Z 13.6K followers, 16.8K engagements

"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"
X Link @MSollender 2025-07-11T20:32Z 13.6K followers, 18.4K engagements

"$CLDX Celldex Reports Results from Phase X Study of Barzolvolimab in Eosinophilic Esophagitis (EoE) Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a primary driver in EoE"
X Link @MSollender 2025-08-19T20:03Z 13.6K followers, 9024 engagements

"(1/3) It's the home stretch for 2025 already Here are some catalysts for 4Q25 and in red some that I have my eye on Let me know if I missed your favorite event $AGIO $ALEC $ALKS $ANAB $APGE $ARGX $BBIO $BDTX $BHVN $BLTE $CABA $CAPR $CELC $CGEM $CNTA $COGT $CRBP $CYTK"
X Link @MSollender 2025-10-01T10:48Z 13.6K followers, 20.1K engagements

"(2/3) Some intriguing make-or-break data sets for companies as well as some modality readouts are upcoming $DRUG $DYN $ELDN $EWTX $FGEN $FULC $GPCR $IFRX $IMNM $IMVT $INCY $INSM $IRON $JANX $JAZZ $KRRO $LXEO $MIST $MLTX $MREO $MRSN $NKTR"
X Link @MSollender 2025-10-01T10:50Z 13.6K followers, 4155 engagements

"$PALI Palisade Bio Announces Closing of Upsized $XXX Million Public Offering of Common Stock and Including Full Exercise of Over-Allotment Option"
X Link @MSollender 2025-10-02T20:08Z 13.6K followers, 7000 engagements

"$BMEA Offering 🫠"
X Link @MSollender 2025-10-06T20:19Z 13.6K followers, 8261 engagements

"@jq1234t Next one is $16B at this rate"
X Link @MSollender 2025-10-02T21:07Z 13.6K followers, 1442 engagements

"$GLTO $ACXP $XBIO What are we doing here"
X Link @MSollender 2025-10-08T08:43Z 13.6K followers, 6794 engagements

creator/x::MSollender
/creator/x::MSollender